Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cassava Sciences Inc (NQ: SAVA )

2.750 -0.040 (-1.43%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 13, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,307,491
Open 2.790
Bid (Size) 2.750 (1)
Ask (Size) 2.790 (4)
Prev. Close 2.790
Today's Range 2.690 - 2.840
52wk Range 2.690 - 42.20
Shares Outstanding 41,969,994
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Shareholders that Lost Money on Cassava Sciences, Inc. (SAVA) Should Contact Levi & Korsinsky about Pending Class Action - SAVA
Via ACCESSWIRE
Investors in Cassava Sciences, Inc. Should Contact Levi & Korsinsky Before February 10, 2025 to Discuss Your Rights - SAVA
Via ACCESSWIRE

Performance

YTD
-87.73%
-87.73%
1 Month
-89.08%
-89.08%
3 Month
-90.22%
-90.22%
6 Month
-86.05%
-86.05%
1 Year
-90.87%
-90.87%

More News

Read More
Rosen Law Firm Urges Cassava Sciences, Inc. (NASDAQ: SAVA) Stockholders with Large Losses in Excess of $100K to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
Cassava Sciences, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - SAVA
Via ACCESSWIRE
SAVA LAWSUIT ALERT: Levi & Korsinsky Notifies Cassava Sciences, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
Via ACCESSWIRE
Unpacking the Latest Options Trading Trends in Cassava Sciences
Via Benzinga
Top Biotech Short Squeeze Stocks
Via Talk Markets
Topics Stocks / Equities
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
S&P 500, Nasdaq Hit Record Highs To Start December
Via Talk Markets
Topics Stocks Stocks / Equities
Exposures US Equities
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Benzinga Bulls And Bears: Amazon, Tesla, Rivian, Palantir And How Dogecoin Helped Low-Income Families Achieve Homeownership
Via Benzinga
This Goldman Sachs Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Via Benzinga
Cassava Sciences, Zoom, Kohl's, Rivian, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Gold Down Over 3%; Rigetti Computing Shares Spike Higher
Via Benzinga
Crude Oil Down 3%; Chicago Fed National Activity Index Falls In October
Via Benzinga
Topics Economy
Exposures Fossil Fuels Interest Rates
'Pharma Bro' Martin Shkreli Tells Investors To 'Short SAVA,' Stock Falls Over 80% After Phase 3 Update
Via Benzinga
Dow Surges Over 300 Points; Bath & Body Works Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
Cassava Sciences Alzheimer's Drug Fails To Hit Primary Goal In Pivotal Study, Pharma Halts Late-Stage Studies
Via Benzinga
Cassava Sciences Plummets 85% After Embattled Alzheimer's Drug Flops
Via Investor's Business Daily
Cassava Sciences, Biohaven And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
Cassava Sciences Topline Phase 3 Data Did Not Meet Co-Primary Endpoints
From Cassava Sciences, Inc.
Via GlobeNewswire
Cassava Sciences to Hold Corporate Update on November 25th
From Cassava Sciences, Inc.
Via GlobeNewswire
Cassava Sciences Appoints Freda Nassif as Chief Commercial Officer
From Cassava Sciences, Inc.
Via GlobeNewswire
Friday's Top 5 Trending Stocks: What's The Scoop On GameStop, SoFi, Tesla?
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.